| Inhalation drug delivery devices: technology update M Ibrahim, R Verma, L Garcia-Contreras Medical Devices: Evidence and Research, 131-139, 2015 | 391 | 2015 |
| Intracellular time course, pharmacokinetics, and biodistribution of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to mice RK Verma, J Kaur, K Kumar, AB Yadav, A Misra Antimicrobial agents and chemotherapy 52 (9), 3195-3201, 2008 | 108 | 2008 |
| A hand-held apparatus for “nose-only” exposure of mice to inhalable microparticles as a dry powder inhalation targeting lung and airway macrophages J Kaur, P Muttil, RK Verma, K Kumar, AB Yadav, R Sharma, A Misra European journal of pharmaceutical sciences 34 (1), 56-65, 2008 | 90 | 2008 |
| Emerging Applications of Nanoparticles and Architecture Nanostructures A Barhoum, ASH Makhlouf Elsevier, 2018 | 85 | 2018 |
| Inhaled microparticles containing clofazimine are efficacious in treatment of experimental tuberculosis in mice RK Verma, WA Germishuizen, MP Motheo, AK Agrawal, AK Singh, ... Antimicrobial agents and chemotherapy 57 (2), 1050-1052, 2013 | 76 | 2013 |
| Efficient, enzyme responsive and tumor receptor targeting gelatin nanoparticles decorated with concanavalin-A for site-specific and controlled drug delivery for cancer therapy K Vaghasiya, E Ray, R Singh, K Jadhav, A Sharma, R Khan, OP Katare, ... Materials Science and Engineering: C 123, 112027, 2021 | 61 | 2021 |
| Investigations into an alternate approach to target mannose receptors on macrophages using 4-sulfated N-acetyl galactosamine more efficiently in comparison with mannose … D Singodia, A Verma, RK Verma, PR Mishra Nanomedicine: Nanotechnology, Biology and Medicine 8 (4), 468-477, 2012 | 60 | 2012 |
| Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis A Ahmad, MM Ansari, RK Mishra, A Kumar, A Vyawahare, RK Verma, ... Materials Science and Engineering: C 119, 111582, 2021 | 54 | 2021 |
| Dynamic mucus penetrating microspheres for efficient pulmonary delivery and enhanced efficacy of host defence peptide (HDP) in experimental tuberculosis A Sharma, K Vaghasiya, P Gupta, AK Singh, UD Gupta, RK Verma Journal of Controlled Release 324, 17-33, 2020 | 51 | 2020 |
| Lung anatomy and physiology and their implications for pulmonary drug delivery RK Verma, M Ibrahim, L Garcia‐Contreras Pulmonary drug delivery: advances and challenges, 1-18, 2015 | 48 | 2015 |
| Matrix metalloproteinase-responsive mesoporous silica nanoparticles cloaked with cleavable protein for “self-actuating” on-demand controlled drug delivery for cancer therapy K Vaghasiya, E Ray, A Sharma, OP Katare, RK Verma ACS Applied Bio Materials 3 (8), 4987-4999, 2020 | 44 | 2020 |
| Inhalable Microparticles Containing Nitric Oxide Donors: Saying NO to Intracellular Mycobacterium tuberculosis RK Verma, AK Singh, M Mohan, AK Agrawal, PRP Verma, A Gupta, ... Molecular pharmaceutics 9 (11), 3183-3189, 2012 | 43 | 2012 |
| RGD modified albumin nanospheres for tumour vasculature targeting PK Dubey, D Singodia, RK Verma, SP Vyas Journal of Pharmacy and Pharmacology 63 (1), 33-40, 2011 | 42 | 2011 |
| Silymarin encapsulated nanoliquid crystals for improved activity against beta amyloid induced cytotoxicity A Singh, A Kumar, RK Verma, R Shukla International Journal of Biological Macromolecules 149, 1198-1206, 2020 | 39 | 2020 |
| Partial biodistribution and pharmacokinetics of isoniazid and rifabutin following pulmonary delivery of inhalable microparticles to rhesus macaques RK Verma, JK Mukker, RSP Singh, K Kumar, PRP Verma, A Misra Molecular pharmaceutics 9 (4), 1011-1016, 2012 | 39 | 2012 |
| Inhalable microparticles containing isoniazid and rifabutin target macrophages and ‘stimulate the phagocyte’to achieve high efficacy AB Yadav, R Sharma, P Muttil, AK Singh, RK Verma, M Mohan, SK Patel, ... CSIR, 2009 | 37 | 2009 |
| Autophagy-inducing inhalable co-crystal formulation of niclosamide-nicotinamide for lung cancer therapy E Ray, K Vaghasiya, A Sharma, R Shukla, R Khan, A Kumar, RK Verma AAPS PharmSciTech 21, 1-14, 2020 | 35 | 2020 |
| Inhalable microparticles of nitric oxide donors induce phagosome maturation and kill Mycobacterium tuberculosis RK Verma, AK Agrawal, AK Singh, M Mohan, A Gupta, P Gupta, UD Gupta, ... Tuberculosis 93 (4), 412-417, 2013 | 35 | 2013 |
| Temperature/pH-triggered PNIPAM-based smart nanogel system loaded with anastrozole delivery for application in cancer chemotherapy A Singh, K Vaishagya, R K. Verma, R Shukla Aaps Pharmscitech 20 (5), 213, 2019 | 34 | 2019 |
| Microparticles induce variable levels of activation in macrophages infected with Mycobacterium tuberculosis AB Yadav, P Muttil, AK Singh, RK Verma, M Mohan, AK Agrawal, ... Tuberculosis 90 (3), 188-196, 2010 | 32 | 2010 |
Amit MisraScientist, CSIR-Central Drug Research Institute, Lucknow, India在 cdri.res.in 的电子邮件经过验证
